Captopril Modifies Gene Expression in Hypertrophied and Failing Hearts of Aged Spontaneously Hypertensive Rats

Author:

Brooks Wesley W.1,Bing Oscar H. L.1,Conrad Chester H.1,O’Neill Lydia1,Crow Michael T.1,Lakatta Edward G.1,Dostal David E.1,Baker Kenneth M.1,Boluyt Marvin O.1

Affiliation:

1. From the Department of Veterans Affairs Medical Center, Boston, Mass; the Department of Medicine, Boston University School of Medicine, Boston, Mass; the Weis Center for Research, Geisinger Clinic, Danville, Pa; and the Laboratory of Cardiovascular Science, Gerontology Research Center, National Institute on Aging, National Institutes of Health, Baltimore, Md.

Abstract

Abstract The spontaneously hypertensive rat (SHR) exhibits a transition from stable compensated left ventricular (LV) hypertrophy to heart failure (HF) at a mean age of 21 months that is characterized by a decrease in α-myosin heavy chain (α-MHC) gene expression and increases in the expression of the atrial natriuretic factor (ANF), pro-α 1 (III) collagen, and transforming growth factor β 1 (TGF-β 1 ) genes. We tested the hypotheses that angiotensin-converting enzyme inhibition (ACEI) in SHR would prevent and reverse HF-associated changes in gene expression when administered prior to and after the onset of HF, respectively. We also investigated the effect of ACEI on circulating and cardiac components of the renin-angiotensin system. ACEI (captopril 2 g/L in the drinking water) was initiated at 12, 18, and 21 months of age in SHR without HF and in SHR with HF. Results were compared with those of age-matched normortensive Wistar-Kyoto (WKY) rats, and to untreated SHR with and without evidence of HF. ACEI initiated prior to failure prevented the changes in α-MHC, ANF, pro-α 1 (III) collagen, and TGF-β 1 gene expression that are associated with the transition to HF. ACEI initiated after the onset of HF lowered levels of TGF-β 1 mRNA by 50% ( P <.05) and elevated levels of α-MHC mRNA two- to threefold ( P <.05). Circulating levels of renin and angiotensin I were elevated four- to sixfold by ACEI, but surprisingly, plasma levels of angiotensin II were not reduced. ACEI increased LV renin mRNA levels in WKY and SHR by two- to threefold but did not influence LV levels of angiotensinogen mRNA. The results suggest that the anti-HF benefits of ACEI in SHR may be mediated, at least in part, by effects on the expression of specific genes, including those encoding α-MHC, ANF, TGF-β 1 , pro-α 1 (III) collagen, and renin-angiotensin system components.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Internal Medicine

Cited by 43 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3